gut microbiota
The findings of a recent study may help researchers to characterize the composition of the human gut microbiota in health and disease.
MaaT033 (capsule), which is being developed as an adjunctive and maintenance therapy to improve overall survival in allo-HSCT, has received orphan drug designation (ODD) status from the European Medicines Agency…
New Study Demonstrates Positive Effects of NORDBIOTIC Probiotic Strains on Irritable Bowel Syndrome (IBS) in Adult Patient.
Elisa Cirillo, team lead research data manager at The Hyve, talks about the importance of having high quality data and strong tools to improve the microbiome research and business.
The findings of a recent study suggest that FMT is an effective strategy to mitigate the intestinal side effects of cancer immunotherapy.
Understanding how gut microbes are linked to preclinical Alzheimer’s disease could help to identify markers of disease risk.
Jeroen Raes, from KU Leuven, Belgium, talks about the design of clinical trials for IBD patient with microbiome based therapies.
Lihi Godny, from Rabin Medical Center in Israel, talks about the next steps research has to focus in to improve the FMT efficacy for IBD patients.
According to the authors, results suggest that patients with a specific microbial signature have a more favorable response to therapy.
A recent review highlights that changes in fear-related mental health conditions are observed when the gut microbiota is altered or removed.
